Funder
Biomedical Advanced Research and Development Authority
U.S. Department of Health and Human Services
Reference10 articles.
1. CDC, Centers for Disease Control [Internet]. The Threat of an Anthrax Attack accessed at: https://www.cdc.gov/anthrax/bioterrorism/threat.html. Last updated 20Nov2020.
2. Jernigan JA, Stephens DS, Ashford DA, et al. Bioterrorism-Related Inhalational Anthrax: The First 10 Cases Reported in the United States. Emerging Infectious Diseases. 2001 Nov-Dec;7(6):933-944.
3. Jernigan, Daniel B; Raghunathan, Pratima L; Bell, Beth P; Brechner, Ross; Bresnitz, Eddy A; Butler, Jay C; et al. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerging Infectious Diseases. 2002. Volume 8(10):1019-1028.
4. Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence;Shepard;Emerg Infect Dis,2002
5. Use of Anthrax Vaccine in the United States. Advisory Committee on Immunization Practices, MMWR, December 15, 2000 / 49 (RR15); 1-20.